BioSpace News Archive

MolecuLight Inc., the leader in point-of-care fluorescence imaging for real-time detection of bacteria in wounds, announces the availability of its MolecuLight i:X® platform on theEpic App Orchard Marketplace and the integration of its platform with Epic’s leading EMR platform.

Cellular Biomedicine Group, Inc. announced today that it has signed a definitive merger agreement to be acquired by a newly-formed entity formed on behalf of a consortium consisting of Bizuo Liu and certain other members of CBMG management...

TC-210 patient with partial response confirmed by independent central review and tumor regression improved further from 42% to 75%

Trillium Therapeutics Inc. (“Trillium” or the “Company”) (NASDAQ/TSX: TRIL), a clinical stage immuno-oncology company developing innovative therapies for the treatment of cancer, today reported financial and operating results for the six months ended June 30, 2020.

Ascendis Pharma A/S (Nasdaq: ASND), a biopharmaceutical company that utilizes its innovative TransCon technologies to address unmet medical needs, today announced the European Commission (EC) has granted Orphan Designation to TransCon C-Type Natriuretic Peptide (CNP) for the treatment of achondroplasia, the most common form of dwarfism

Evotec SE announced its financial results for the first half-year of 2020.

According to a new market report published by Transparency Market Research “Scar Treatment Market – Global Industry Analysis, Size, Share, Growth, Trends & Forecast, and 2019 – 2027”.

Peripheral nerve regeneration is a slow process, which is usually incomplete unlike other tissues in the body.

The global organoids market is a fragmented landscape with several new players driving intense competition and rising investment in innovation.

The demand within the global market for life science microscopy devices has been rising on account of advancements in the domain of medical research and development, finds Transparency Market Research.